| pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels P Geeleher, N Cox, RS Huang PloS one 9 (9), e107468, 2014 | 1496 | 2014 |
| Clinical drug response can be predicted using baseline gene expression levels and in vitrodrug sensitivity in cell lines P Geeleher, NJ Cox, RS Huang Genome biology 15, 1-12, 2014 | 683 | 2014 |
| oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data D Maeser, RF Gruener, RS Huang Briefings in bioinformatics 22 (6), bbab260, 2021 | 582 | 2021 |
| The draft genome of the grass carp (Ctenopharyngodon idellus) provides insights into its evolution and vegetarian adaptation Y Wang, Y Lu, Y Zhang, Z Ning, Y Li, Q Zhao, H Lu, R Huang, X Xia, ... Nature genetics 47 (6), 625-631, 2015 | 427 | 2015 |
| Evaluation of genetic variation contributing to differences in gene expression between populations W Zhang, S Duan, EO Kistner, WK Bleibel, RS Huang, TA Clark, TX Chen, ... The American Journal of Human Genetics 82 (3), 631-640, 2008 | 238 | 2008 |
| A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity RS Huang, S Duan, WK Bleibel, EO Kistner, W Zhang, TA Clark, TX Chen, ... Proceedings of the National Academy of Sciences 104 (23), 9758-9763, 2007 | 235 | 2007 |
| A microfluidics approach for the isolation of nucleated red blood cells (NRBCs) from the peripheral blood of pregnant women R Huang, TA Barber, MA Schmidt, RG Tompkins, M Toner, DW Bianchi, ... Prenatal Diagnosis: published in Affiliation with the International Society …, 2008 | 211 | 2008 |
| Pharmacogenetics and pharmacogenomics of anticancer agents RS Huang, MJ Ratain CA: a cancer journal for clinicians 59 (1), 42-55, 2009 | 199 | 2009 |
| Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach RS Huang, S Duan, SJ Shukla, EO Kistner, TA Clark, TX Chen, ... The American Journal of Human Genetics 81 (3), 427-437, 2007 | 194 | 2007 |
| Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma T Best, D Li, AD Skol, T Kirchhoff, SA Jackson, Y Yasui, S Bhatia, ... Nature medicine 17 (8), 941-943, 2011 | 188 | 2011 |
| Population differences in microRNA expression and biological implications RS Huang, ER Gamazon, D Ziliak, Y Wen, HK Im, W Zhang, C Wing, ... RNA biology 8 (4), 692-701, 2011 | 183 | 2011 |
| Genetic architecture of transcript-level variation in humans S Duan, RS Huang, W Zhang, WK Bleibel, CA Roe, TA Clark, TX Chen, ... The American Journal of Human Genetics 82 (5), 1101-1113, 2008 | 174 | 2008 |
| Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy L Weng, L Zhang, Y Peng, RS Huang Pharmacogenomics 14 (3), 315-324, 2013 | 145 | 2013 |
| Chemotherapeutic drug susceptibility associated SNPs are enriched in expression quantitative trait loci ER Gamazon, RS Huang, NJ Cox, ME Dolan Proceedings of the National Academy of Sciences 107 (20), 9287-9292, 2010 | 137 | 2010 |
| Pharmacogenomic discovery using cell-based models M Welsh, L Mangravite, MW Medina, K Tantisira, W Zhang, RS Huang, ... Pharmacological reviews 61 (4), 413-429, 2009 | 135 | 2009 |
| Genetic architecture of microRNA expression: implications for the transcriptome and complex traits ER Gamazon, D Ziliak, HK Im, B LaCroix, DS Park, NJ Cox, RS Huang The American Journal of Human Genetics 90 (6), 1046-1063, 2012 | 118 | 2012 |
| Identification of MicroRNAs as breast cancer prognosis markers through the cancer genome atlas JTH Chang, F Wang, W Chapin, RS Huang PloS one 11 (12), e0168284, 2016 | 113 | 2016 |
| Circulating microRNAs as biomarkers for inflammatory diseases S Mi, J Zhang, W Zhang, RS Huang Microrna 2 (1), 64-72, 2013 | 105 | 2013 |
| Discovering novel pharmacogenomic biomarkers by imputing drug response in cancer patients from large genomics studies P Geeleher, Z Zhang, F Wang, RF Gruener, A Nath, G Morrison, S Bhutra, ... Genome research 27 (10), 1743-1751, 2017 | 103 | 2017 |
| Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity CM Hartford, S Duan, SM Delaney, S Mi, EO Kistner, JK Lamba, ... Blood, The Journal of the American Society of Hematology 113 (10), 2145-2153, 2009 | 103 | 2009 |
